146 related articles for article (PubMed ID: 28035350)
1. Silencing LPAATβ inhibits tumor growth of cisplatin-resistant human osteosarcoma in vivo and in vitro.
Song L; Duan P; Gan Y; Li P; Zhao C; Xu J; Zhang Z; Zhou Q
Int J Oncol; 2017 Feb; 50(2):535-544. PubMed ID: 28035350
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAATβ.
Song L; Yang J; Duan P; Xu J; Luo X; Luo F; Zhang Z; Hou T; Liu B; Zhou Q
Arch Biochem Biophys; 2013 Jul; 535(2):128-35. PubMed ID: 23578572
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid acyltransferase β (LPAATβ) promotes the tumor growth of human osteosarcoma.
Rastegar F; Gao JL; Shenaq D; Luo Q; Shi Q; Kim SH; Jiang W; Wagner ER; Huang E; Gao Y; Shen J; Yang K; He BC; Chen L; Zuo GW; Luo J; Luo X; Bi Y; Liu X; Li M; Hu N; Wang L; Luther G; Luu HH; Haydon RC; He TC
PLoS One; 2010 Dec; 5(12):e14182. PubMed ID: 21152068
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circ-CHI3L1.2 modulates cisplatin resistance of osteosarcoma cells via the miR-340-5p/LPAATβ axis.
Zhang Z; Zhou Q; Luo F; Zhou R; Xu J; Xiao J; Dai F; Song L
Hum Cell; 2021 Sep; 34(5):1558-1568. PubMed ID: 34164774
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma.
Song L; Duan P; Gan Y; Li P; Zhao C; Xu J; Zhang Z; Zhou Q
Braz J Med Biol Res; 2017 Apr; 50(5):e6359. PubMed ID: 28443990
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of BMI-1 promotes cell growth and resistance to cisplatin treatment in osteosarcoma.
Wu Z; Min L; Chen D; Hao D; Duan Y; Qiu G; Wang Y
PLoS One; 2011 Feb; 6(2):e14648. PubMed ID: 21311599
[TBL] [Abstract][Full Text] [Related]
8. RLN2 Is a Positive Regulator of AKT-2-Induced Gene Expression Required for Osteosarcoma Cells Invasion and Chemoresistance.
Ma J; Huang H; Han Z; Zhu C; Yue B
Biomed Res Int; 2015; 2015():147468. PubMed ID: 26229955
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of KRT17 decreases osteosarcoma cell proliferation and the Warburg effect via the AKT/mTOR/HIF1α pathway.
Yan X; Yang C; Hu W; Chen T; Wang Q; Pan F; Qiu B; Tang B
Oncol Rep; 2020 Jul; 44(1):103-114. PubMed ID: 32627037
[TBL] [Abstract][Full Text] [Related]
10. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
11. TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma.
Li C; Cai J; Ge F; Wang G
Int J Mol Med; 2018 Oct; 42(4):1799-1808. PubMed ID: 30015899
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells.
Sun X; Wei Q; Cheng J; Bian Y; Tian C; Hu Y; Li H
Hum Cell; 2017 Jul; 30(3):216-225. PubMed ID: 28326487
[TBL] [Abstract][Full Text] [Related]
13. GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy.
Kim M; Jung JY; Choi S; Lee H; Morales LD; Koh JT; Kim SH; Choi YD; Choi C; Slaga TJ; Kim WJ; Kim DJ
Autophagy; 2017 Jan; 13(1):149-168. PubMed ID: 27754745
[TBL] [Abstract][Full Text] [Related]
14. Silencing of Glucose Transporter Protein-1 by RNA Interference Inhibits Human Osteosarcoma Mg63 Cells Growth in vivo.
Jian F; Yuan F; Jiong M; Zhu XZ; Yu GR; Lu DD
Technol Cancer Res Treat; 2015 Apr; 14(2):243-8. PubMed ID: 24502553
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q
Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383
[TBL] [Abstract][Full Text] [Related]
16. EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling.
Cheng DD; Li SJ; Zhu B; Zhou SM; Yang QC
J Exp Clin Cancer Res; 2018 Mar; 37(1):50. PubMed ID: 29510727
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of a cisplatin‑resistant human osteosarcoma cell line.
Han T; Zhu X; Wang J; Zhao H; Ma Q; Zhao J; Qiu X; Fan Q
Oncol Rep; 2014 Sep; 32(3):1133-9. PubMed ID: 25017716
[TBL] [Abstract][Full Text] [Related]
18. P-Glycoprotein Overexpression Is Associated With Cisplatin Resistance in Human Osteosarcoma.
He C; Sun Z; Hoffman RM; Yang Z; Jiang Y; Wang L; Hao Y
Anticancer Res; 2019 Apr; 39(4):1711-1718. PubMed ID: 30952710
[TBL] [Abstract][Full Text] [Related]
19. ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo.
Jullien N; Dieudonné FX; Habel N; Marty C; Modrowski D; Patino A; Lecanda F; Sévère N; Marie PJ
Gene; 2013 May; 521(1):55-61. PubMed ID: 23541807
[TBL] [Abstract][Full Text] [Related]
20. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma.
Xiao X; Wang W; Li Y; Yang D; Li X; Shen C; Liu Y; Ke X; Guo S; Guo Z
J Exp Clin Cancer Res; 2018 Aug; 37(1):201. PubMed ID: 30153855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
